Company / Income Tax
Lineage Cell Therapeutics, Inc. Income Tax History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
-$5.3M
FY2025
5-year range
-$5.3M / $541.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 8 years, ranging from -$7M in FY2020 to $541,000 in FY2022.
Based on SEC 10-K filings.
-$5M in FY2025.
Improved from -$2M to -$5M over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Peak income tax was recorded in FY2022.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$5.3M | - |
| FY2024 | $0 | +100.0% |
| FY2023 | -$1.8M | -433.3% |
| FY2022 | $541.0K | +143.7% |
| FY2021 | -$1.2M | +83.3% |
| FY2020 | -$7.4M | -2240.8% |
| FY2019 | $346.0K | +200.0% |
| FY2018 | -$346.0K | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026